PKU HealthCare Corp.,Ltd. (SHE:000788)
China · Delayed Price · Currency is CNY 6.12
-0.13 (-2.08%)
Apr 30, 2026, 3:04 PM CST
PKU HealthCare Corp.,Ltd. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,195 | 1,482 | 2,055 | 2,189 | 2,072 | 2,231 |
Other Revenue | - | - | 5.43 | 4.68 | 4.93 | 6.19 |
| 1,195 | 1,482 | 2,060 | 2,194 | 2,077 | 2,237 | |
Revenue Growth (YoY) | -42.22% | -28.04% | -6.10% | 5.61% | -7.13% | 13.12% |
Cost of Revenue | 827.03 | 1,067 | 1,512 | 1,482 | 1,305 | 1,328 |
Gross Profit | 368.15 | 415.56 | 548.39 | 711.92 | 772.12 | 908.96 |
Selling, General & Admin | 204.87 | 225.45 | 311.94 | 577.18 | 653.29 | 769.44 |
Research & Development | 26.51 | 26.86 | 27.04 | 27.8 | 14.74 | 14.08 |
Other Operating Expenses | 4.03 | 4.98 | 9.31 | 11.09 | 11.45 | 12.26 |
Operating Expenses | 235.42 | 257.29 | 336.76 | 613.71 | 678.28 | 808.08 |
Operating Income | 132.73 | 158.27 | 211.62 | 98.21 | 93.84 | 100.88 |
Interest Expense | - | - | -4.17 | -6.98 | -18.48 | -22.78 |
Interest & Investment Income | 8.88 | 6.89 | 5.03 | 6.37 | 6.96 | 6.75 |
Currency Exchange Gain (Loss) | - | - | -0 | -0 | -0.01 | 0 |
Other Non Operating Income (Expenses) | -24.95 | -25.05 | -0.2 | -0.18 | -0.17 | -0.17 |
EBT Excluding Unusual Items | 116.66 | 140.11 | 212.28 | 97.42 | 82.15 | 84.69 |
Gain (Loss) on Sale of Investments | 0.2 | - | -0.24 | -1.16 | -1.54 | - |
Gain (Loss) on Sale of Assets | 0.01 | 0.03 | 0.19 | 0.01 | 1.12 | - |
Asset Writedown | -37.47 | -37.48 | -42.16 | -19.93 | -12.72 | -25.76 |
Legal Settlements | - | - | - | -0.53 | -5.72 | -2.68 |
Other Unusual Items | - | - | 2.28 | -1.52 | 7.3 | 5.66 |
Pretax Income | 79.4 | 102.67 | 172.35 | 74.29 | 70.59 | 61.91 |
Income Tax Expense | 15.16 | 19.78 | 34.36 | 29.94 | 15.17 | 18.76 |
Earnings From Continuing Operations | 64.24 | 82.88 | 137.99 | 44.35 | 55.42 | 43.15 |
Minority Interest in Earnings | - | - | - | 0 | 0.19 | -0 |
Net Income | 64.24 | 82.88 | 137.99 | 44.36 | 55.61 | 43.14 |
Net Income to Common | 64.24 | 82.88 | 137.99 | 44.36 | 55.61 | 43.14 |
Net Income Growth | -53.98% | -39.94% | 211.10% | -20.23% | 28.88% | 10.11% |
Shares Outstanding (Basic) | 596 | 596 | 596 | 596 | 596 | 596 |
Shares Outstanding (Diluted) | 596 | 596 | 596 | 596 | 596 | 596 |
Shares Change (YoY) | -0.03% | -0.02% | -0.03% | 0.03% | 0.01% | 6.46% |
EPS (Basic) | 0.11 | 0.14 | 0.23 | 0.07 | 0.09 | 0.07 |
EPS (Diluted) | 0.11 | 0.14 | 0.23 | 0.07 | 0.09 | 0.07 |
EPS Growth | -53.97% | -39.91% | 211.16% | -20.26% | 28.87% | 3.43% |
Free Cash Flow | 587.57 | 338.53 | 308.38 | 58.65 | 243.57 | 13.74 |
Free Cash Flow Per Share | 0.99 | 0.57 | 0.52 | 0.10 | 0.41 | 0.02 |
Dividend Per Share | - | - | 0.080 | 0.026 | - | 0.023 |
Dividend Growth | - | - | 207.69% | - | - | - |
Gross Margin | 30.80% | 28.03% | 26.62% | 32.45% | 37.17% | 40.64% |
Operating Margin | 11.11% | 10.68% | 10.27% | 4.48% | 4.52% | 4.51% |
Profit Margin | 5.38% | 5.59% | 6.70% | 2.02% | 2.68% | 1.93% |
Free Cash Flow Margin | 49.16% | 22.84% | 14.97% | 2.67% | 11.72% | 0.61% |
EBITDA | 164.89 | 189.95 | 241.39 | 127.15 | 119.65 | 121.87 |
EBITDA Margin | 13.80% | 12.81% | 11.72% | 5.80% | 5.76% | 5.45% |
D&A For EBITDA | 32.16 | 31.68 | 29.77 | 28.93 | 25.81 | 20.99 |
EBIT | 132.73 | 158.27 | 211.62 | 98.21 | 93.84 | 100.88 |
EBIT Margin | 11.11% | 10.68% | 10.27% | 4.48% | 4.52% | 4.51% |
Effective Tax Rate | 19.09% | 19.27% | 19.94% | 40.30% | 21.49% | 30.30% |
Revenue as Reported | - | - | 2,060 | 2,194 | 2,077 | 2,237 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.